We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$1.92B
AUM Growth
+$154M
Cap. Flow
+$53M
Cap. Flow %
2.76%
Top 10 Hldgs %
26.22%
Holding
151
New
15
Increased
40
Reduced
15
Closed
11

Top Buys

Rank Stock Value
1
JELD icon
JELD-WEN Holding
JELD
+$18.8M
2
LII icon
Lennox International
LII
+$14.6M
3
AVXS
AveXis, Inc. Common Stock
AVXS
+$8.18M
4
TTD icon
Trade Desk
TTD
+$8.01M
5
VRNS icon
Varonis Systems
VRNS
+$7.91M

Top Sells

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$21.1M
2
CYBR
CyberArk
CYBR
+$14M
3
ABBV icon
AbbVie
ABBV
+$10.1M
4
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$9.2M
5
XPO icon
XPO
XPO
+$7.1M

Sector Composition

Rank Sector Weight
1 Healthcare 40.8%
2 Technology 16.87%
3 Consumer Discretionary 13.92%
4 Industrials 10.12%
5 Utilities 5.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XPO icon
1
XPO
XPO
$20.9B
$72.2M 3.76%
2,278,418
-277,574
-11% -$7.1M
ASND icon
2
Ascendis Pharma A/S
ASND
$15.8B
$53.4M 2.78%
1,332,540
+128,000
+11% +$4.65M
LOW icon
3
Lowe's Companies
LOW
$109B
$52.5M 2.74%
565,000
– –
W icon
4
Wayfair
W
$14.2B
$50.2M 2.62%
626,000
+61,000
+11% +$4.29M
BLUE
5
DELISTED
bluebird bio
BLUE
$49.4M 2.58%
21,431
-10,375
-33% -$21.1M
MIC
6
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$47.3M 2.47%
737,100
+6,000
+0.8% +$406K
AVXS
7
DELISTED
AveXis, Inc. Common Stock
AVXS
$46.6M 2.43%
421,000
+81,471
+24% +$8.18M
AIMT
8
DELISTED
Aimmune Therapeutics
AIMT
$46.4M 2.42%
1,226,000
+196,000
+19% +$6.32M
ABBV icon
9
AbbVie
ABBV
$465B
$43.2M 2.25%
447,000
-107,500
-19% -$10.1M
LRCX icon
10
Lam Research
LRCX
$339B
$41.8M 2.18%
2,270,000
– –
COLL icon
11
Collegium Pharmaceutical
COLL
$711M
$40.8M 2.12%
2,207,610
– –
STLD icon
12
Steel Dynamics
STLD
$34.3B
$37.6M 1.96%
871,000
– –
WBC
13
DELISTED
WABCO HOLDINGS INC.
WBC
$36.7M 1.91%
255,600
– –
WCN
14
Waste Connections
WCN
$40.1B
$36.7M 1.91%
517,000
+97,000
+23% +$6.78M
MGA icon
15
Magna International
MGA
$17B
$34.6M 1.8%
610,000
+1,500
+0.2% +$82.5K
CCI icon
16
Crown Castle
CCI
$31.2B
$33.9M 1.77%
305,000
-2,000
-0.7% -$216K
XIFR
17
XPLR Infrastructure LP
XIFR
$1.04B
$33.7M 1.76%
782,600
-9,400
-1% -$378K
LEA icon
18
Lear
LEA
$6.22B
$32.5M 1.69%
184,000
– –
TTD icon
19
Trade Desk
TTD
$7.05B
$31.5M 1.64%
6,890,000
+1,450,000
+27% +$8.01M
OPLN
20
Openlane
OPLN
$4.26B
$30.8M 1.61%
1,611,620
+87,186
+6% +$1.61M
SAGE
21
DELISTED
Sage Therapeutics
SAGE
$30.4M 1.59%
184,600
+25,600
+16% +$2.48M
STKL
22
DELISTED
SunOpta
STKL
$30.2M 1.58%
3,902,025
+15,025
+0.4% +$125K
ASML icon
23
ASML
ASML
$611B
$29.9M 1.56%
172,000
– –
SNA icon
24
Snap-on
SNA
$19.4B
$28.6M 1.49%
164,365
+865
+0.5% +$140K
CELG
25
DELISTED
Celgene Corp
CELG
$28.6M 1.49%
274,300
– –
1
2 3 4 5

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Eventide Asset Management held 151 positions worth $1.92B, up 8.7% from $1.76B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management's Q4 2017 filing shows 15 new, 40 increased, 15 reduced and 11 closed positions. Its largest new stake was JELD-WEN Holding: 506,500 shares worth $19.9M. The largest sale was bluebird bio, an estimated $21.1M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 42% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Eventide Asset Management's largest Q4 2017 buy was JELD-WEN Holding: 506,500 shares worth $19.9M.
  • Eventide Asset Management added most to AveXis, Inc. Common Stock in Q4 2017, an estimated $8.18M increase.
  • Eventide Asset Management's biggest Q4 2017 reduction was bluebird bio, cutting an estimated $21.1M.
  • Eventide Asset Management fully exited CyberArk in Q4 2017, selling an estimated $14M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $1.92B portfolio in Q4 2017.
  • Eventide Asset Management opened 15 new positions and closed 11 in Q4 2017.
  • Eventide Asset Management's portfolio value rose 8.7% quarter-over-quarter to $1.92B.

Based on Eventide Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.